Coordinated selling by both the CEO and CFO is a strong negative signal, especially in absence of a disclosed personal reason (e.g., pre-arranged plan). Traders should watch for downward pressure on the stock and monitor upcoming earnings or guidance for signs of weakening fundamentals.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 23 $48.09entry
- T+1 · 9mo ago +0.94%α +0.20% · $48.54
- T+5 · 9mo ago −4.57%α −5.19% · $45.89
- T+20 · 8mo ago −7.47%α −3.52% · $44.50
- T+60 · 6mo ago +3.54%α −4.72% · $49.79
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three insiders at Twist Bioscience Corp sold shares in a coordinated open-market transaction on February 23, 2026, including CEO Emily Leproust and CFO Adam Laponis. The cluster represents over $473,000 in total value, with both C-suite executives participating in the selling.
Key Financial Metrics
Key Facts
- CEO Emily Leproust sold 7,205 shares for $336,544.11 in open-market transaction.
- CFO Adam Laponis sold 2,085 shares for $97,389.93 in open-market transaction.
- Dennis Cho (role not specified in filing but likely insider) sold 844 shares for $39,423.07.
- All transactions occurred on the same day at the same price, indicating coordination.
- Total value of insider sales: $473,357.11 in a single day.
Financial Impact
$473,357 in net insider selling over one day
Risk Factors
- Insider selling may indicate lack of confidence in near-term prospects.
- Concentrated sell-off by top executives could spook retail and institutional investors.
- Potential for further selling if this is part of a larger divestment trend.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-TWST-1772053906486 |
Track record
47 reports on TWST
7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $105.04 +0.01% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $105.04 −0.11% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $105.04 +0.06% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $105.04 −0.54% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $105.04 +0.98% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $105.04 −8.04% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $105.04 −20.50% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $105.04 −13.04% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $105.04 −12.91% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers